Abiomed, Inc. (ABMD) Tops Q4 EPS by 7c; Revs Heavy

Abiomed, Inc. (NASDAQ: ABMD) reported Q4 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $37.3 million versus the consensus estimate of $34.98 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• Arena Group to rename as Paradium.AI, ticker changing to PAAI